SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 6th, 2017 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 3, 2017, between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • November 6th, 2017 • Bio-Path Holdings Inc • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE WARRANT bio-path holdings, inc.Common Stock Purchase Warrant • November 6th, 2017 • Bio-Path Holdings Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”), dated as of November __, 2017, certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after November __, 2017 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November __, 2022 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
LEAK-OUT AGREEMENTLeak-Out Agreement • November 6th, 2017 • Bio-Path Holdings Inc • Pharmaceutical preparations
This agreement (the “Leak-Out Agreement”) is being delivered to you in connection with an understanding by and among Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and the person or persons named on the signature pages hereto (collectively, the “Holder”).
